Faus Moliner participates in the EU Pharmaceutical Law Forum

Jordi Faus participated in the dialogue Market Access Challenges and Developments for Pharmaceutical Firms

The 33rd edition of the European Pharmaceutical Law Forum, organized by Informa Connect, took place in Brussels from May 21-23, 2024.

As in previous editions, several round tables have addressed key issues and developments in EU Pharmaceutical Law.

Jordi Faus, together with Ilja Moree (Novartis AG) and Christian Jervelund (Copenhagen Economics), addressed the challenges faced by pharmaceutical companies in market access, as well as legal developments in this area. In his presentation, Jordi Faus presented various ideas on drug pricing and the nature of pricing and financing decisions. In addition, he explained how deferred payment systems and more sophisticated payment by results agreements can facilitate this access. He also highlighted the impact of drug price transparency in this area.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información. ACEPTAR

Aviso de cookies